28 June-1 July Barcelona
![]() |
![]() |
![]() |
![]() |
1-P | Gastric cancer: Artificial intelligence, complex system analysis and simulation for best management | Oleg Kshivets | ![]() |
![]() |
|||
5-P | A Soluble resistance related calcium binding protein (Sorcin) up-regulates in the multi-drug resistant advanced gastric cancer patients | Sushmita Ghosh | ![]() |
![]() |
|||
8-PD | HERIZON: A Phase 2 study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine plus SOC chemotherapy in patients with HER2 advanced stomach Cancer-Correlation of the antibody responses and clinical outcome | Joshua Tobias | ![]() |
![]() |
|||
13-P | Management of Metastatic Colorectal Cancer in Patients &8805;70 Years - A Single Center Experience | Florian Huemer | ![]() |
![]() |
|||
20-P | Pseudoglandular pattern in hepatocellular neoplasms and its diagnostic value with cytokeratin immunostain | Lee-Ching Zhu | ![]() |
![]() |
|||
27-PD | The use of pre-operative systemic oxaliplatin or irinotecan doublet chemotherapy in colorectal cancer peritoneal metastases (CRPM): Results from a single UK peritoneal tumour centre | Nadina Tinsley | ![]() |
![]() |
|||
48-P | Outcomes of early gall bladder cancer (GBCA): A retrospective analysis from a tertiary care centre in India | Joydeep Ghosh | ![]() |
![]() |
|||
68-P | Impact of specimens and fixation status on HER2 assessment in the treatment of advanced gastric cancer (HER_WEEKEND study) | Michio Nakamura | ![]() |
![]() |
|||
77-P | Multisite intratumoral chemotherapy improves treatment outcome in a murine model with pancreatic ductal adenocarcinoma | Ron Epelbaum | ![]() |
![]() |
|||
104-P | Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Preliminary results from a multi-cohort, multi-center phase II trial (ALTER-G-001) | Huimin Wang | ![]() |
![]() |
|||
120-P | Efficacy of systemic therapy for advanced hepatocellular carcinoma based on etiology: a systematic review and network meta-analysis | Charlene Hoi Lam Wong | ![]() |
![]() |
|||
135-P | Detection of RAS gene mutations in patients with metastatic colorectal cancer during cetuximab-based first-line treatment and survival of the patients in relation to changes in RAS gene status | Marian Stresko | ![]() |
![]() |
|||
175-P | Next-generation sequencing in colorectal cancer patients: characterization and prognostic implications | Federico Longo | ![]() |
![]() |
|||
210-P | Efficacy and tolerability of cetuximab 750 mg/m2 every three weeks in metastatic colorectal cancer | Mohamed Aseafan | ![]() |
![]() |
|||
221-P | Prediction of colon cancer recurrence based on proteomic biomarkers | Soledad Cameselle-Garcia | ![]() |
![]() |
|||
240-P | Frequency and management of trifluridine/tipiracil (FTD/TPI) bevacizumab (BEV)-associated neutropenia in patients with refractory metastatic colorectal cancer (mCRC) in real-world practice | Nieves Martínez Lago | ![]() |
![]() |
|||
278-P | Survival impact and predictive scores for thrombosis associated with pancreatic ductal adenocarcinoma (PDAC) | Alejandra Romano | ![]() |
![]() |
|||
333-P | Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer | Yana Chikhareva | ![]() |
![]() |
|||
419-P | Safety and effectiveness analysis of neoadjuvant chemoradiation plus consolidative chemotherapy with concurrent anti-pd-1 therapy in mid-low locally advanced rectal cancer | Xinliang Liu | ![]() |
![]() |
28 June-1 July Barcelona
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|